A carregar...
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients
AIMS/INTRODUCTION: This study evaluated the efficacy and safety of mirogabalin, a novel, potent, selective ligand of the α(2)δ subunit of voltage‐dependent Ca(2+) channels, for the treatment of diabetic peripheral neuropathic pain (DPNP). MATERIALS AND METHODS: During this double‐blind, multisite, p...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717827/ https://ncbi.nlm.nih.gov/pubmed/30672128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|